apalutamide will lessen the level or effect of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medications which can be CYP3A4 substrates can lead to reduced publicity to these medications.  The estimated track record chance of key start